arsenic trioxide has been researched along with artesunic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Efferth, T; Hoheisel, JD; Youns, M | 1 |
| Feng, L; Jiang, W; Li, Y; Shan, N; Wang, X | 1 |
| He, R; Huang, J; Liu, S; Pan, X; Shao, Y; Shi, T; Xi, J; Yu, W; Zhuang, R | 1 |
1 review(s) available for arsenic trioxide and artesunic acid
| Article | Year |
|---|---|
Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours.
Topics: Animals; Antineoplastic Agents, Phytogenic; Arsenic Trioxide; Arsenicals; Artemisinins; Artesunate; Berberine; Biological Products; Cantharidin; Complementary Therapies; Curcumin; Drug Delivery Systems; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Models, Biological; Neoplasms; Oxides | 2010 |
2 other study(ies) available for arsenic trioxide and artesunic acid
| Article | Year |
|---|---|
Artesunate possesses anti-leukemia properties that can be enhanced by arsenic trioxide.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Artemisinins; Artesunate; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Fas Ligand Protein; fas Receptor; Humans; K562 Cells; Leukemia; Oxides; Proto-Oncogene Proteins c-fos; U937 Cells | 2014 |
pH-Responsive and liver-targeting drug delivery system for combination delivery of artesunate with arsenic trioxide prodrug against hepatocellular carcinoma.
Topics: Antineoplastic Agents; Arsenic Trioxide; Artesunate; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Liposomes; Liver Neoplasms; Polyethylene Glycols; Prodrugs | 2023 |